Zynex Submits FDA Application for its Next Generation NMES Device

ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: FDA PDT Source Type: news